Company intelligence / Profile preview

Sypharma

Dandenong, Victoria, Australia

Ownership: Private
Employees: ~71
Development stage: Other

Overview

Sypharma manufactures a variety of pharmaceutical products including liquid biopharmaceuticals for clinical trials (Phase I-III) and commercial supply, for both human and veterinary markets. It is experienced in supplying both sterile and non-sterile (powder, liquid, cream) therapeutic goods. The company is involved in the development and manufacturing of clinical trial materials and has supported, for example, Australian COVID-19 vaccine programs.[1][2][3][4][5]

Modalities: Small moleculeBiologicLarge volume parenteralSmall volume parenteralOral drugTopical drugVaccine
Industry: Contract Manufacturing Organization

Partnerships

VaxineTechnovaliaBioNetSchott

Beyond the preview

Go deeper on Sypharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sypharma.

Explore the full profile